Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Krispy Kreme Inc (DNUT) Price & Performance

Definium Therapeutics Inc. Common SharesTrade
Krispy Kreme IncTrade

Price performance (Past 24H)

Key statistics

Definium Therapeutics Inc. Common Shares vs Krispy Kreme Inc — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.59B), while Krispy Kreme Inc trades at $3.01 (market cap $521.37M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 8.8× Krispy Kreme Inc's market cap, and Krispy Kreme Inc pays a 3.47% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Krispy Kreme Inc for 45 Days on average.

DFTXDNUT
Market Cap
$4.59B$521.37M
Volume
2,103,9372,293,015
Sector
HealthConsumer Staples
52-Week High
$48.45$4.70
52-Week Low
$10.68$2.87
Typical Hold Time
0 Days45 Days
Enterprise Value
$3.55B$1.76B
Dividend Yield
—3.47%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Definium Therapeutics Inc. Common Shares

No Aura AI signal available yet.

Krispy Kreme Inc

Krispy Kreme (DNUT) trades at $2.92, down 3.31% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $515.77M in 2025, with a negative net income margin of -33.88%, though revenue remains stable at $1.52B. Recent news highlights ongoing legal investigations into fiduciary duties of officers and directors, alongside seasonal product launches like the Pokémon doughnut collection.

The outlook is mixed; analyst consensus leans buy (50%) with a low P/S of 0.34 offering value, but profitability challenges and legal overhangs pose significant risks. Cash flow improved in 2025, yet high debt and negative ROE of -14.43% demand caution for stock investors seeking turnaround potential amid competitive pressures.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DFTX
100% Buy0% Sell
Avg holding period · 0 Days
DNUT
0% Buy100% Sell
Avg holding period · 45 Days

About Definium Therapeutics Inc. Common Shares

Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.

Read more on DFTX →

About Krispy Kreme Inc

Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates in 30 countries through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S. and Canada, includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line

Read more on DNUT →